Impel Pharmaceuticals Inc (IMPLQ)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Adrian Adams
Employees:
130
201 ELLIOTT AVE. W, SUITE 260, SEATTLE, WA, 98119
206-568-1466
Impel NeuroPharma, Inc. focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|